South Korean team behind promising stroke research, treatment cites Chinese interest
Experimental treatment improves motor function in animals with ischemic stroke.
South Korean researchers have discovered a novel therapeutic pathway for ischemic stroke, long considered one of medicine's toughest challenges. Their study, published in Cell Metabolism, reveals that oxidative stress-induced astrocytic collagen biosynthesis drives glial barrier formation and neuronal death. An experimental drug targeting this mechanism significantly improved motor function and reduced brain damage in animal models.
Chinese doctors have expressed interest in partnering to further develop the treatment. Ischemic stroke, caused by a blood clot blocking a cerebral vessel, affects over 100,000 patients annually in South Korea (population 52 million). Survivors often face severe motor disabilities and cognitive decline, and treatment is limited by a three-hour 'golden time' window. This breakthrough could expand therapeutic options and improve outcomes.
- Study published in Cell Metabolism identifies a new ischemic stroke pathway involving astrocytic collagen biosynthesis.
- Experimental drug improved motor function and reduced brain damage in animal models.
- Chinese medical teams are interested in collaborating to advance the treatment toward clinical use.
Why It Matters
Potential new therapy could drastically improve stroke outcomes and expand the narrow treatment window.